CACNA2D3
Basic information
Region (hg38): 3:54122552-55074557
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CACNA2D3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 57 | 61 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 4 | 2 | 7 | ||
non coding | 16 | 26 | ||||
Total | 0 | 0 | 74 | 13 | 10 |
Variants in CACNA2D3
This is a list of pathogenic ClinVar variants found in the CACNA2D3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-54122720-G-C | not specified | Uncertain significance (Dec 08, 2023) | ||
3-54122727-G-T | not specified | Uncertain significance (Oct 25, 2023) | ||
3-54122729-TCGCCG-T | not provided (-) | |||
3-54122748-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
3-54122753-G-A | not specified | Uncertain significance (Aug 26, 2022) | ||
3-54122760-C-T | CACNA2D3-related disorder | Uncertain significance (Mar 05, 2024) | ||
3-54122790-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
3-54123535-T-C | not specified | Uncertain significance (Aug 15, 2023) | ||
3-54123552-A-C | not specified | Uncertain significance (Oct 04, 2023) | ||
3-54123560-C-T | not specified | Uncertain significance (Dec 20, 2021) | ||
3-54123563-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
3-54123582-G-C | not specified | Uncertain significance (Aug 02, 2021) | ||
3-54123583-C-G | not specified | Uncertain significance (Sep 20, 2023) | ||
3-54320459-G-GA | CACNA2D3-related disorder | Uncertain significance (Jul 27, 2023) | ||
3-54320483-T-T | Benign (Dec 17, 2018) | |||
3-54320553-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
3-54386694-G-GTTTTT | CACNA2D3-related disorder | Likely benign (Jan 21, 2020) | ||
3-54386694-G-GTTTTTTT | CACNA2D3-related disorder | Likely benign (Feb 20, 2020) | ||
3-54386721-G-A | not specified | Uncertain significance (May 27, 2022) | ||
3-54503548-G-C | not specified | Uncertain significance (Mar 30, 2024) | ||
3-54503630-G-A | CACNA2D3-related disorder | Uncertain significance (May 10, 2024) | ||
3-54562834-A-C | not specified | Uncertain significance (Jan 23, 2023) | ||
3-54562853-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
3-54562904-G-A | not specified | Uncertain significance (Nov 10, 2022) | ||
3-54562940-A-C | Benign (Apr 30, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CACNA2D3 | protein_coding | protein_coding | ENST00000474759 | 38 | 952011 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.578 | 0.422 | 124649 | 0 | 23 | 124672 | 0.0000922 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.86 | 451 | 577 | 0.782 | 0.0000314 | 7200 |
Missense in Polyphen | 181 | 255.5 | 0.7084 | 3024 | ||
Synonymous | -0.0763 | 218 | 217 | 1.01 | 0.0000132 | 1964 |
Loss of Function | 5.99 | 15 | 68.5 | 0.219 | 0.00000367 | 812 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000117 | 0.000117 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000557 | 0.0000556 |
Finnish | 0.000195 | 0.000186 |
European (Non-Finnish) | 0.000107 | 0.000106 |
Middle Eastern | 0.0000557 | 0.0000556 |
South Asian | 0.0000659 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel. Acts as a regulatory subunit for P/Q-type calcium channel (CACNA1A), N-type (CACNA1B), L-type (CACNA1C OR CACNA1D) but not T-type (CACNA1G) (By similarity). {ECO:0000250}.;
- Pathway
- Oxytocin signaling pathway - Homo sapiens (human);Cardiac muscle contraction - Homo sapiens (human);Dilated cardiomyopathy (DCM) - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Celecoxib Pathway, Pharmacodynamics;Arrhythmogenic Right Ventricular Cardiomyopathy;MAPK Signaling Pathway;Neuronal System;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Cardiac conduction;Muscle contraction;Presynaptic depolarization and calcium channel opening;Transmission across Chemical Synapses
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.84
- rvis_percentile_EVS
- 11.45
Haploinsufficiency Scores
- pHI
- 0.661
- hipred
- Y
- hipred_score
- 0.614
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.178
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cacna2d3
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of ion transmembrane transport;calcium ion transmembrane transport
- Cellular component
- plasma membrane;voltage-gated calcium channel complex
- Molecular function
- voltage-gated calcium channel activity;metal ion binding